Establishment and characterization of bone marrow mesenchymal stem cell lines stably synthesizing high-level dopamine.
- Author:
Yang LIU
1
;
Junyan CHANG
1
;
Yue WANG
1
;
Pan YANG
1
;
Caiyun MA
1
;
Gaofeng LIU
1
;
Yu GUO
2
;
Changqing LIU
1
;
Chunjing WANG
1
Author Information
- Publication Type:Journal Article
- Keywords: GTP cyclohydrolase 1; Parkinson's disease (PD); dopamine; dopamine decarboxylase; rat mesenchymal stem cells; tyrosine hydroxylase
- MeSH: Rats; Animals; Dopamine; Parkinson Disease/metabolism*; Mesenchymal Stem Cells/metabolism*; Cell Line; Brain/metabolism*; Cell Differentiation; Mesenchymal Stem Cell Transplantation
- From: Chinese Journal of Biotechnology 2023;39(4):1773-1788
- CountryChina
- Language:Chinese
- Abstract: A triple-transgenic (tyrosine hydroxylase/dopamine decarboxylase/GTP cyclohydrolase 1, TH/DDC/GCH1) bone marrow mesenchymal stem cell line (BMSCs) capable of stably synthesizing dopamine (DA) transmitters were established to provide experimental evidence for the clinical treatment of Parkinson's disease (PD) by using this cell line. The DA-BMSCs cell line that could stably synthesize and secrete DA transmitters was established by using the triple transgenic recombinant lentivirus. The triple transgenes (TH/DDC/GCH1) expression in DA-BMSCs was detected using reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and immunofluorescence. Moreover, the secretion of DA was tested by enzyme-linked immunosorbent assay (ELISA) and high-performance liquid chromatography (HPLC). Chromosome G-banding analysis was used to detect the genetic stability of DA-BMSCs. Subsequently, the DA-BMSCs were stereotactically transplanted into the right medial forebrain bundle (MFB) of Parkinson's rat models to detect their survival and differentiation in the intracerebral microenvironment of PD rats. Apomorphine (APO)-induced rotation test was used to detect the improvement of motor dysfunction in PD rat models with cell transplantation. The TH, DDC and GCH1 were expressed stably and efficiently in the DA-BMSCs cell line, but not expressed in the normal rat BMSCs. The concentration of DA in the cell culture supernatant of the triple transgenic group (DA-BMSCs) and the LV-TH group was extremely significantly higher than that of the standard BMSCs control group (P < 0.000 1). After passage, DA-BMSCs stably produced DA. Karyotype G-banding analysis showed that the vast majority of DA-BMSCs maintained normal diploid karyotypes (94.5%). Moreover, after 4 weeks of transplantation into the brain of PD rats, DA-BMSCs significantly improved the movement disorder of PD rat models, survived in a large amount in the brain microenvironment, differentiated into TH-positive and GFAP-positive cells, and upregulated the DA level in the injured area of the brain. The triple-transgenic DA-BMSCs cell line that stably produced DA, survived in large numbers, and differentiated in the rat brain was successfully established, laying a foundation for the treatment of PD using engineered culture and transplantation of DA-BMSCs.
